The diagnosis and treatment of late-life depression

Journal of Clinical Psychiatry

Volumn 57, Issue SUPPL. 5, 1996, Pages 5-11

  Rothschild, Anthony J ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; DESIPRAMINE; DOXEPIN; IMIPRAMINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AGED; DEPRESSION; DIFFERENTIAL DIAGNOSIS; ELECTROCONVULSIVE THERAPY; HUMAN; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; REVIEW; SYMPTOM;

AGE FACTORS; AGED; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; BUPROPION; CYCLOHEXANOLS; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; LITHIUM; MALE; MONOAMINE OXIDASE INHIBITORS; SEROTONIN UPTAKE INHIBITORS; SEX FACTORS; TRAZODONE; TRIAZOLES;

EID: 0029897595     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. NIH Consensus Development Panel on Depression in Late Life. Diagnosis and treatment of depression. JAMA 1992;268:1018-1024
2. Rovner BW, German PS, Brant LJ, et al. Depression and mortality in nursing homes. JAMA 1991;265:993-996
3. Fitten LJ, Morley JE, Gross PL, et al. Depression (clinical conference). J Am Geriatr Soc 1989:37:459-472
4. Dreyfus JK. Depression assessment and interventions in the medically ill frail elderly. J Gerontol Nurs 1988:14:27-36
5. Hendrie HC, Crosset JHW. An overview of depression in the elderly. Psychiatric Annals 1990;20:64-70
6. Kalayam B, Shamoian CA. Geriatric psychiatry: an update. J Clin Psychiatry 1990;51:177-183
7. Ruegg RG, Zisook S, Swerdlow NR. Depression in the aged: an overview. Psychiatr Clin North Am 1988;11:83-99
8. Salzman C, Shader RI. Depression in the elderly, I: relationship between depression, psychological defense mechanisms and physical illness. J Am Geriatr Soc 1978;26:253-260
9. Fisch RZ, Nesher G. Masked depression: help for the hidden misery. Postgrad Med 1986;80:165-169
10. Lesse S. The masked depression syndrome: results of a 17-year clinical study. Am J Psychother 1983;37:465-475
11. Blazer D, Bachar JR, Hughes DC. Major depression with melancholia: a comparison of middle-aged and elderly adults. J Am Genatr Soc 1987; 35:927-932
12. Dessonville C, Gallagher D, Thompson LW, et al. Relationship of age and health status of depressive symptoms in normal and depressed older adults. Essence 1982;5:99-110
13. Zung W. A self-rating depression scale. Arch Gen Psychiatry 1965:12:63-70
14. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571
15. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1983:17:37-49
16. Dunner DL. Therapeutic considerations in treating depression in the elderly. J Clin Psychiatry 1994:55(12, suppl):48-58
17. McCullough PK. Geriatric depression: atypical presentations, hidden meanings. Geriatrics 1991;46:72-77
18. Baker FM. A contrast: geriatric depression versus depression in younger age groups. J Natl Med Assoc 1991;83:340-344
19. Salzman C. Pharmacologic treatment of depression in the elderly. J Clin Psychiatry 1993;54(2,suppl):23-28
20. Thompson LW, Futterman A, Gallagher D. Assessment of late-life depression. Psychopharmacol Bull 1988;24:577-586
21. Meyers BS, Alexopoulos GS. Geriatric depression. Med Clin North Am 1988;72:847-866
22. Wood KA, Harris MJ, Morreale A, et al. Drug-induced psychosis and depression in the elderly. Psychiatr Clin North Am 1988;11:167-193
23. Reding M, Haycox J, Blass J. Depression in patients referred to a dementia clinic: a three-year prospective study. Arch Neurol 1985;42:894-896
24. Dunner DL. Diagnostic and treatment considerations for the depressed elderly patient. In: Serotonin: Reshaping the Treatment of Depression. Philadelphia, Pa: The Medicine Publishing Foundation; 1992:43-52
25. Coryell W. Anxiety secondary to depression. Psychiatr Clin North Am 1990;13:685-698
26. Thompson LW. Cognitive-behavioral therapy and treatment for late-life depression. J Clin Psychiatry 1996;57(suppl 5):29-37
27. Finkel SI. Efficacy and toterability of antidepressant therapy in the old-old. J Clin Psychiatry 1996;57(suppl 5):23-28
28. Newhouse PA. Use of serotonin selective reuptake inhibitors in geriatric depression. J Clin Psychiatry 1996;57(suppl 5):12-22
29. Oxman TE. Antidepressants and cognitive impairment in the elderly. J Clin Psychiatry 1996;57(suppl 5):38-44
30. Salzman C, Hoffman SA. Clinical interaction between psychotropic and other drugs. Hosp Community Psychiatry 1983;34:897-902
31. Salzman C, Nevis-Olesen J. Psychopharmacologic treatment. In: Birren JE, Sloane RB, Cohen GD, eds. Handbook of Mental Health and Aging. 2nd ed. New York, NY: Academic Press; 1992:721-762
32. Sacchetti E, Conte G, Guarneri L. Are SSRIs a clinically homogeneous class of compounds? [letter] Lancet 1994;344:126-127
33. Carroll BJ. Are SSRI antidepressants clinically homogeneous? [letter] Lancet 1994;344:550
34. Stewart JT. Diagnosing and treating depression in the hospitalized elderly. Geriatrics 1991;46:64-72
35. Ray WA, Griffin MR. Cyclic antidepressants and risk of hip fracture. Arch Intern Med 1991;151:754-756
36. Tiller JWG. Antidepressants, alcohol, and psychomotor performance. Acta Psychiatr Scand Suppl 1990;82(suppl 360):13-17
37. Cutter NR, Narang BK. Implications of dosing tricyclic antidepressants and benzodiazepines in geriatrics. Psychiatr Clin North Am 1987;7: 845-861
38. Salzman C. Clinical use of antidepressanl blood levels and the electrocardiogram [editorial], N Engl J Med 1985;313:512-513
39. Salzman C. Pharmacologic treatment of depression in the elderly. In: Schneider LS, Reynolds CF, Lebowitz BD, et al, eds. Diagnosis and Treatment of Depression in the Elderly: Results of the NIH/NIMH Consensus Development Conference. Washington, DC: American Psychiatric Press; 1993:181-244
40. Dessain EC, Schatzberg AF, Woods BT, et al. Maprotiline treatment in depression: a perspective on seizures. Arch Gen Psychiatry 1986;43:86-90
41. Cohen BM, Harris PQ, Altesman RI, et al. Amoxapine: neuroleptic as well as antidepressant? Am J Psychiatry 1982;139:1165-1167
42. Nierenberg AA, Adler LA, Peselow E, et al. Trazodone for antidepressant-associated insomnia. Am J Psychiatry 1994; 151:1069-1072
43. Branconnier RJ, Cole JO, Ghazvinian S, et al. Clinical pharmacology of bupropion and imipramine in elderly depressives. J Clin Psychiatry 1983; 44(5, sec 2):130-133
44. Kane JM, Cole K, Sarantakos S, et al. Safety and efficacy of bupropion in elderly patients: preliminary observations. J Clin Psychiatry 1983;44(5, sec 2):134-136
45. Physicians' Desk Reference. 49th ed. Montvale, NJ: Medical Economics; 1995:1855,2389
46. Teicher MH, Cohen BM, Baldessarini RJ, et al. Severe daytime somnolence in patients treated with an MAOI. Am J Psychiatry 1988;145: 1552-1556
47. Richelson E. Synaptic pharmacology of antidepressants: an update. McLean Hosp J 1988;13:67-88
48. Tulloch IF, Johnson AM. The pharmacologic profile of paroxetine: a new selective serotonin reuptake inhibitor. J Clin Psychiatry 1992;53(2, suppl): 7-12
49. Heym J, Koe BK. Pharmacology of sertraline: a review. J Clin Psychiatry 1988;49(8, suppl):40-45
50. Baldessarini RJ. Current status of antidepressants: clinical pharmacology and therapy. J Clin Psychiatry 1989;50:117-126
51. Grimsley SR, Jann MW. Paroxetine, sertraline and fluvoxamine: new selective serotonin reuptake inhibitors. Clinical Pharmacy 1992;11:930-957
52. Dunner DL. An overview of paroxetine in the elderly. Gerontology 1994; 40(suppl 1):21-27
53. Feighner JP, Boyer WF, Meredith CH, et al. An overview of fluoxetine in geriatric depression. Br J Psychiatry 1988;153(suppl 3):105-108
54. Cohn CK, Shrivastava R, Mendels J, et al. Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients. J Clin Psychiatry 1990;51(12, suppl B):28-33
55. DeVane CL. Pharmacokinetics of the selective serotonin reuptake inhibitors. J Clin Psychiatry 1992;53(2, suppl):13-20
56. Doogan DP, Caillard V. Sertraline: a new antidepressant. J Clin Psychiatry 1988;49(8,suppl):46-51
57. Rickels K, Schweizer E. Clinical overview of serotonin reuptake inhibitors. J Clin Psychiatry 1990;51(12, suppl B):9-12
58. Ciraulo DA, Shader RI. Fluoxetine drug-drug interactions, I; Antidepressants and antipsychotics, II. J Clin Psychopharmacol 1990;10:48-50, 213-217
59. Preskom S. Recent pharmacologic advances in antidepressant therapy for the elderly. Am J Med 1993;94(suppl 5A):2S-12S
60. Crewe HK, Lennard MS, Tucker GT, et al. The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes. Br J Clin Pharmacol 1992;34:262-265
61. Broson K, Hansen JG, Nielsen KK, et al. Inhibition by paroxetine or desipramine metabolism in extensive but not in poor metabolizers of sparteine. Eur J Clin Pharmacol 1993;44:349-355
62. Preskorn S. Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline. Int Clin Psychopharmacol 1994;9(suppl 3):13-19
63. Preskorn SH, Alderman J, Chung M, et al. Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine. J Clin Psychopharmacol 1994;14:90-98
64. von Moltke LL, Greenblatt DJ, Cotreau-Bibbo MM, et al. Inhibitors of alprazolam metabolism in vitro: effect of serotonin-reuptake-inhibitor antidepressants, ketoconazole, and quinidine. Br J Clin Pharmacol 1994;37: 23-31
65. Lasher TA, Fleishaker JC, Stenwyk RC, et al. Pharmacokinetic pharmacodynamic evaluation of the combined administration of alprazolam and fluoxetine. Psychopharmacology (Berl) 1991;104:323-327
66. Greenblatt DJ, Preskorn SH, Cotreau MM, et al. Fluoxetine impairs clearance of alprazolam but not clonazepam. Clin Pharmacol Ther 1992;52: 479-486
67. Lemberger L, Rowe H, Bosomworth JC, et al. The effect of fluoxetine on the pharmacokinetics and psychomotor response of diazepam. Clin Pharmacol Ther 1988;43:412-419
68. Otton SW, Wu D, Joffe RT, et al. Inhibition by fluoxetine of cytochrome P4502D6 activity. Clin Pharmacol Ther 1993;53:401-409
69. Muth EA, Haskins JT, Moyer JA, et al. Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative. Biochem Pharmacol 1986;35:4493-4497
70. Venlafaxine: a new dimension in antidepressant pharmacotherapy [ACADEMIC HIGHLIGHTS]. J Clin Psychiatry 1993;54:119-126
71. Venlafaxine. Physicians' Desk Reference. 49th ed. Montvale, NJ: Medical Economics; 1995:2664-2665
72. Schweizer E, Weise C, Clary C, et al. Placebo-controlled trial of venlafaxine for the treatment of major depression. J Clin Psychopharmacol 1991; 11:233-236
73. Nierenberg A, Feighner JP, Rudolph R, et al. Venlafaxine for treatment-resistant unipolar depression. J Clin Psychopharmacol 1994;14:419-423
74. DeMontigny C, Grunberg F, Mayer A, et al. Lithium induces rapid relief from depression in tricyclic antidepressant drug nonresponders. Br J Psychiatry 1981;138:252-256
75. Eison AE, Eison MS, Torrente JR, et al. Nefazodone: preclinical pharmacology of a new antidepressant. Psychopharmacol Bull 1990;26:311-315
76. Nefazodone. Physicians' Desk Reference. 50th ed. Montvale, NJ: Medical Economics; 1996:771-775
77. Jenike MA. Affective illness. In: Jenike MA, ed. Handbook of Geriatric Psychopharmacology. Littleton, Mass: PSG Publishing; 1985:39-95
78. Cummings JL. Disturbances of mood and affect. In: Cummings JL, ed. Clinical Neuropsychiatry. Orlando, Fla: Grune & Stratton; 1985:183-208
79. Jenike MA. Treatment of affective illness in the elderly with drugs and electroconvulsive therapy. J Geriatr Psychiatry 1989;22:77-112
80. Cattan RA, Barry PP, Mead G, el al. Electroconvulsive therapy in octogenarians. J Am Geriatr Soc 1990;38:753-758